Janus Henderson Group PLC grew its holdings in Medidata Solutions, Inc. (NASDAQ:MDSO) by 10.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 882,164 shares of the company’s stock after purchasing an additional 84,161 shares during the period. Janus Henderson Group PLC owned about 1.51% of Medidata Solutions worth $68,985,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Alps Advisors Inc. grew its holdings in shares of Medidata Solutions by 0.3% in the second quarter. Alps Advisors Inc. now owns 8,430 shares of the company’s stock worth $659,000 after acquiring an additional 22 shares during the period. World Asset Management Inc grew its holdings in shares of Medidata Solutions by 1.2% in the second quarter. World Asset Management Inc now owns 3,528 shares of the company’s stock worth $276,000 after acquiring an additional 43 shares during the period. State Board of Administration of Florida Retirement System grew its holdings in shares of Medidata Solutions by 0.3% in the second quarter. State Board of Administration of Florida Retirement System now owns 33,828 shares of the company’s stock worth $2,645,000 after acquiring an additional 109 shares during the period. Pinebridge Investments L.P. grew its holdings in shares of Medidata Solutions by 2.1% in the second quarter. Pinebridge Investments L.P. now owns 7,305 shares of the company’s stock worth $572,000 after acquiring an additional 153 shares during the period. Finally, Municipal Employees Retirement System of Michigan grew its holdings in shares of Medidata Solutions by 1.6% in the first quarter. Municipal Employees Retirement System of Michigan now owns 12,470 shares of the company’s stock worth $719,000 after acquiring an additional 200 shares during the period. 97.52% of the stock is owned by institutional investors and hedge funds.

Medidata Solutions, Inc. (NASDAQ MDSO) opened at 79.45 on Friday. The company’s 50-day moving average price is $76.33 and its 200 day moving average price is $72.79. The stock has a market capitalization of $4.50 billion, a P/E ratio of 128.35 and a beta of 1.77. Medidata Solutions, Inc. has a 52-week low of $46.10 and a 52-week high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last released its earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.03. Medidata Solutions had a return on equity of 11.14% and a net margin of 7.07%. The firm had revenue of $137.41 million for the quarter, compared to the consensus estimate of $134.28 million. During the same period in the prior year, the firm earned $0.24 EPS. The firm’s revenue was up 19.9% on a year-over-year basis. On average, equities research analysts predict that Medidata Solutions, Inc. will post $1.29 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/10/13/medidata-solutions-inc-mdso-shares-bought-by-janus-henderson-group-plc.html.

In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $74.53, for a total transaction of $372,650.00. The sale was disclosed in a filing with the SEC, which is available through this link. 5.80% of the stock is currently owned by company insiders.

Several analysts recently commented on the company. Zacks Investment Research raised Medidata Solutions from a “sell” rating to a “hold” rating in a report on Wednesday, September 20th. Royal Bank Of Canada assumed coverage on Medidata Solutions in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $82.00 price objective for the company. KeyCorp reaffirmed a “buy” rating and issued a $86.00 price objective on shares of Medidata Solutions in a report on Sunday, September 17th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $78.00 price objective on shares of Medidata Solutions in a report on Tuesday, August 22nd. Finally, BidaskClub lowered Medidata Solutions from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $84.64.

Medidata Solutions Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.